Overall Cancer Statistics - Annual Report to the Nation
The Annual Report to the Nation on the Status of Cancer has statistics on cancer deaths and new cases (incidence).
State Cancer Profiles > Quick Profiles
Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for …
Surveillance, Epidemiology, and End Results Program
Apr 16, 2025 · An authoritative source for cancer statistics in the US. We collect incidence, prevalence and survival data and publish reports on these and cancer mortality. For those …
Why Is Early-Onset Cancer On the Rise? - NCI
May 14, 2025 · As diagnoses of colorectal, breast, and other cancers continue to increase in people under age 50, researchers are trying to understand why it’s happening.
Metastatic Cancer: When Cancer Spreads - NCI
Jan 17, 2025 · Metastatic cancer is cancer that spreads from its site of origin to another part of the body. Learn how cancer spreads, possible symptoms, common sites where cancer spreads, …
NIH study investigates trends in early-onset cancers - NCI
May 8, 2025 · The largest absolute increases were seen for female breast cancer, with about 4,800 additional cases in 2019, followed by colorectal (2,100), kidney (1,800), uterine (1,200), …
Cachexia and Cancer - NCI
Oct 15, 2024 · Cancer cachexia is a wasting syndrome in people with advanced cancer. Learn about the causes of cancer cachexia, ways to prevent and manage it, and ideas for getting …
Genetic Testing Fact Sheet - NCI - National Cancer Institute
A fact sheet about genetic testing for inherited cancer risk. Includes who should consider testing, and how to understand test results.
Treatment for Breast Cancer - NCI
Many treatments are available for breast cancer. Learn about local and systemic treatments and access in-depth information about each type of treatment.
CTEP ETCTN - NCI - dctd.cancer.gov
Sep 15, 2025 · The Experimental Therapeutics Clinical Trials Network (ETCTN) conducts early phase cancer clinical trials of CTEP IND agents.